Cumberland Pharmaceuticals (CPIX) EPS (Basic) (2010 - 2026)
Cumberland Pharmaceuticals' (CPIX) quarterly EPS (Basic) came in at -$0.22 in Q1 2026, down 375.0% year-on-year from $0.08 in Q1 2025, and down 144.44% quarter-over-quarter from -$0.09 in Q4 2025.
Cumberland Pharmaceuticals (CPIX) EPS (Basic) (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has disclosed EPS (Basic) across 17 years of filings, most recently posting -$0.22 for Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$0.22, down 375.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.49 (down 96.0% YoY), and the FY2025 annual result was -$0.19, up 58.7% from the prior year.
- EPS (Basic) came in at -$0.22 for Q1 2026 at Cumberland Pharmaceuticals, down from -$0.09 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.08 in Q1 2025 to a low of -$0.44 in Q4 2023.
- The 5-year median for EPS (Basic) is -$0.09 (2022), against an average of -$0.1.
- Across the five-year window, EPS (Basic) surged 166.67% in 2023 and plunged 1500.0% in 2024, its largest moves.
- Cumberland Pharmaceuticals' EPS (Basic) stood at -$0.17 in 2022, then slumped by 158.82% to -$0.44 in 2023, then jumped by 68.18% to -$0.14 in 2024, then soared by 35.71% to -$0.09 in 2025, then plunged by 144.44% to -$0.22 in 2026.
- The last three EPS (Basic) figures came in at -$0.22 (Q1 2026), -$0.09 (Q4 2025), and -$0.13 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.32 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.32 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.97 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -0.40 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.83 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -0.40 |
| 10 | Cumberland Pharmaceuticals | 87.59 Mn | 76.25 Mn | 7.20 Mn | -0.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.22 |
| Dec 31, 2025 | -0.09 |
| Sep 30, 2025 | -0.13 |
| Jun 30, 2025 | -0.05 |
| Mar 31, 2025 | 0.08 |
| Dec 31, 2024 | -0.14 |
| Sep 30, 2024 | -0.11 |
| Jun 30, 2024 | -0.08 |
| Mar 31, 2024 | -0.14 |
| Dec 31, 2023 | -0.44 |
| Sep 30, 2023 | -0.07 |
| Jun 30, 2023 | 0.06 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | -0.17 |
| Sep 30, 2022 | -0.03 |
| Jun 30, 2022 | -0.09 |
| Mar 31, 2022 | -0.09 |
| Dec 31, 2021 | -0.29 |
| Sep 30, 2021 | -0.07 |
| Jun 30, 2021 | 0.08 |